384 related articles for article (PubMed ID: 7539512)
21. Latent membrane protein 1 of Epstein-Barr virus plays an important role in the serum starvation resistance of Epstein-Barr virus-immortalized B lymphocytes.
Park CH; Kim HR; Kim J; Jang SH; Lee KY; Chung GH; Jang YS
J Cell Biochem; 2004 Mar; 91(4):777-85. PubMed ID: 14991769
[TBL] [Abstract][Full Text] [Related]
22. Immortalization of Epstein-Barr virus-infected CD23-negative B lymphocytes by the addition of B cell growth factor.
Azim T; Allday MJ; Crawford DH
J Gen Virol; 1990 Mar; 71 ( Pt 3)():665-71. PubMed ID: 2155999
[TBL] [Abstract][Full Text] [Related]
23. Ligation of centrocyte/centroblast marker 1 on Epstein-Barr virus--transformed B lymphocytes induces cell death in a reactive oxygen species--dependent manner.
Kim YS; Park GB; Choi YM; Kwon OS; Song HK; Kang JS; Kim YI; Lee WJ; Hur DY
Hum Immunol; 2006 Oct; 67(10):795-807. PubMed ID: 17055356
[TBL] [Abstract][Full Text] [Related]
24. In vitro transformation by Epstein-Barr virus induces a switch in growth factor and anti-IgM responsiveness in a human leukemic B cell clone.
Janssen O; Gillis S; Kabelitz D
Eur J Immunol; 1990 Jan; 20(1):7-14. PubMed ID: 2155117
[TBL] [Abstract][Full Text] [Related]
25. Epstein-barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins.
Maeda A; Bandobashi K; Nagy N; Teramoto N; Gogolák P; Pokrovskaja K; Székely L; Björkholm M; Klein G; Klein E
J Hum Virol; 2001; 4(5):227-37. PubMed ID: 11907380
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-2 secretion by human B lymphocytes occurs as a late event and requires additional stimulation after CD40 cross-linking.
Kindler V; Matthes T; Jeannin P; Zubler RH
Eur J Immunol; 1995 May; 25(5):1239-43. PubMed ID: 7539752
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
[TBL] [Abstract][Full Text] [Related]
28. Expression of Epstein-Barr virus transformation-associated genes in tissues of patients with EBV lymphoproliferative disease.
Young L; Alfieri C; Hennessy K; Evans H; O'Hara C; Anderson KC; Ritz J; Shapiro RS; Rickinson A; Kieff E
N Engl J Med; 1989 Oct; 321(16):1080-5. PubMed ID: 2552313
[TBL] [Abstract][Full Text] [Related]
29. Analysis of viral gene expression and genome persistence in CD23-positive and -negative subpopulations of Epstein-Barr-virus-infected BL2 cells.
Doyle MG; Crawford DH
Intervirology; 1994; 37(5):236-44. PubMed ID: 7698878
[TBL] [Abstract][Full Text] [Related]
30. Up regulation of the Epstein-Barr virus (EBV)-encoded membrane protein LMP in the Burkitt's lymphoma line Daudi after exposure to n-butyrate and after EBV superinfection.
Contreras-Salazar B; Ehlin-Henriksson B; Klein G; Masucci MG
J Virol; 1990 Nov; 64(11):5441-7. PubMed ID: 2170681
[TBL] [Abstract][Full Text] [Related]
31. The cytoplasmic C-terminal domain but not the N-terminal domain of latent membrane protein 1 of Epstein-Barr virus is essential for B cell activation.
Peng-Pilon M; Ruuth K; Lundgren E; Brodin P
J Gen Virol; 1995 Apr; 76 ( Pt 4)():767-77. PubMed ID: 9049322
[TBL] [Abstract][Full Text] [Related]
32. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion.
Erickson KD; Martin JM
Virology; 1997 Jul; 234(1):1-13. PubMed ID: 9234942
[TBL] [Abstract][Full Text] [Related]
33. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
[TBL] [Abstract][Full Text] [Related]
34. The expression of Epstein-Barr virus latent proteins is related to the pathological features of post-transplant lymphoproliferative disorders.
Delecluse HJ; Kremmer E; Rouault JP; Cour C; Bornkamm G; Berger F
Am J Pathol; 1995 May; 146(5):1113-20. PubMed ID: 7747805
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr virus latent gene expression during the initiation of B cell immortalization.
Allday MJ; Crawford DH; Griffin BE
J Gen Virol; 1989 Jul; 70 ( Pt 7)():1755-64. PubMed ID: 2544663
[TBL] [Abstract][Full Text] [Related]
37. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
Peng M; Lundgren E
Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
[TBL] [Abstract][Full Text] [Related]
38. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
[TBL] [Abstract][Full Text] [Related]
39. Latent membrane protein of Epstein-Barr virus induces cellular phenotypes independently of expression of Bcl-2.
Martin JM; Veis D; Korsmeyer SJ; Sugden B
J Virol; 1993 Sep; 67(9):5269-78. PubMed ID: 8394449
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
